Here’s who’s eligible and what to consider before deciding.
Articles on Prostate cancer
Displaying 1 - 20 of 98 articles
PSA testing hasn’t been banned – but the row over prostate cancer screening reveals a genuine scientific and ethical dilemma.
When celebrities go public with their prostate cancer diagnoses, they do more than raise awareness.
Jeremy Clarkson says his prostate cancer is ‘aggressive’. Here’s what that actually means.
The treatment is shorter and more convenient, but it will not suit every man with prostate cancer.
This drug is used to treat endometriosis and some breast cancers, but will soon be stripped from Australian shelves.
But for men tested before their mid-60s, risk of overdiagnosis from PSA testing is low.
Women’s HRT patches control prostate cancer as well as standard hormone injections, but with fewer hot flushes and less bone loss, a major UK trial finds.
This new type of immunotherapy shows promise for treating different cancers including prostate cancer, leukaemia and lung cancer.
Modern screening can create patients out of people who never needed treatment in the first place.
For more than 80 years, men have been told that testosterone fuels prostate cancer. But a more nuanced picture has emerged over the past two decades.
Expert panel recommends targeted prostate cancer screening only for men with specific gene mutations.
Up to 15 hospitals will test an AI system that could reshape prostate cancer care for thousands of men.
Two cancer experts go head to head, arguing the case for and against a targeted prostate cancer screening programme.
Although an elevated PSA measurement can indicate prostate cancer, there can be other reasons for elevated levels.
Doctors examine a tumor in several different ways to determine whether a cancer is aggressive – and what kinds of treatments, if any, might work best.
Prostate cancer is one of the most common cancers in men. Although watchful waiting is appropriate for low-risk cases, many are diagnosed at an advanced stage because of racial health disparities.
With bone metastasis and a high Gleason score, Biden’s case is a reminder of the importance of timely screening and comprehensive care.
Here’s what clinicians consider when they calculate a prostate cancer’s Gleason score.
A BBC investigation questioned the accuracy of rapid PSA home tests for prostate health.
Top contributors
-
Professor of Biomedical Sciences, Anglia Ruskin University
-
Head of Urology at Monash Medical Centre and Associate Professor of Surgery, Monash University
-
Professor of Medicine, Bond University
-
Adjunct Clinical Associate Professor, AMREP Department of Medicine, Alfred Hospital, Melbourne & Senior Medical Oncologist and Palliative Care Physician, Melbourne Oncology Group, Cabrini Haematology and Oncology Centre, Wattletree Road, Malvern, Monash University
-
Emeritus Professor in Public Health, University of Sydney
-
Professor of Clinical Epidemiology, Sydney School of Public Health, University of Sydney
-
Senior Research Officer, Blood Cells and Blood Cancer, WEHI (Walter and Eliza Hall Institute of Medical Research)
-
NHMRC Emerging Leader Research Fellow, School of Public Health, University of Sydney
-
Senior Lecturer in Biochemistry, Sheffield Hallam University
-
Research Fellow, Prostate Cancer Research Group, Monash University
-
Senior Research Manager, University of Sydney and Honorary Assistant Professor, Bond University
-
Senior Research Officer, Blood Cells and Blood Cancer Division, WEHI (Walter and Eliza Hall Institute of Medical Research)
-
Senior Associate Vice President Community Health, Education and Training, Old Dominion University; Associate Professor of Pharmacy, University of Florida
-
Professor of Clinical Epidemiology, Bond University
-
Senior Lecturer in Chemical Pathology, University of Westminster